These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30173567)

  • 41. Thiolated polymers as mucoadhesive drug delivery systems.
    Duggan S; Cummins W; O' Donovan O; Hughes H; Owens E
    Eur J Pharm Sci; 2017 Mar; 100():64-78. PubMed ID: 28087353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug delivery from the oral cavity: a focus on mucoadhesive buccal drug delivery systems.
    Shinkar DM; Dhake AS; Setty CM
    PDA J Pharm Sci Technol; 2012; 66(5):466-500. PubMed ID: 23035030
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucoadhesive microspheres for controlled drug delivery.
    Chowdary KP; Rao YS
    Biol Pharm Bull; 2004 Nov; 27(11):1717-24. PubMed ID: 15516712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug Delivery Platforms Containing Thermoresponsive Polymers and Mucoadhesive Cellulose Derivatives: A Review of Patents.
    da Silva JB; Dos Santos RS; Vecchi CF; Bruschi ML
    Recent Adv Drug Deliv Formul; 2022; 16(2):90-102. PubMed ID: 35379163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In Situ Gelling Ophthalmic Drug Delivery System: An Overview and Its Applications.
    Sheshala R; Kok YY; Ng JM; Thakur RR; Dua K
    Recent Pat Drug Deliv Formul; 2015; 9(3):237-48. PubMed ID: 26205681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thiolated poly(aspartic acid) as potential in situ gelling, ocular mucoadhesive drug delivery system.
    Horvát G; Gyarmati B; Berkó S; Szabó-Révész P; Szilágyi BÁ; Szilágyi A; Soós J; Sandri G; Bonferoni MC; Rossi S; Ferrari F; Caramella C; Csányi E; Budai-Szűcs M
    Eur J Pharm Sci; 2015 Jan; 67():1-11. PubMed ID: 25445832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In situ gelling drug delivery systems for topical drug delivery.
    Kolawole OM; Cook MT
    Eur J Pharm Biopharm; 2023 Mar; 184():36-49. PubMed ID: 36642283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Formulation and evaluation of in situ gelling thermoreversible mucoadhesive gel of fluconazole.
    Gonjari ID; Hosmani AH; Karmarkar AB; Godage AS; Kadam SB; Dhabale PN
    Drug Discov Ther; 2009 Feb; 3(1):6-9. PubMed ID: 22495461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chitosan-catechol: a polymer with long-lasting mucoadhesive properties.
    Kim K; Kim K; Ryu JH; Lee H
    Biomaterials; 2015 Jun; 52():161-70. PubMed ID: 25818422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan.
    Majithiya RJ; Ghosh PK; Umrethia ML; Murthy RS
    AAPS PharmSciTech; 2006 Aug; 7(3):67. PubMed ID: 17025248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mucoadhesive drug delivery systems: a promising noninvasive approach to bioavailability enhancement. Part II: formulation considerations.
    Kulkarni R; Fanse S; Burgess DJ
    Expert Opin Drug Deliv; 2023 Mar; 20(3):413-434. PubMed ID: 36803264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transbuccal delivery of betahistine dihydrochloride from mucoadhesive tablets with a unidirectional drug flow: in vitro, ex vivo and in vivo evaluation.
    El-Nabarawi MA; Ali AA; Aboud HM; Hassan AH; Godah AH
    Drug Des Devel Ther; 2016; 10():4031-4045. PubMed ID: 28008227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery.
    Chopra S; Mahdi S; Kaur J; Iqbal Z; Talegaonkar S; Ahmad FJ
    J Pharm Pharmacol; 2006 Aug; 58(8):1021-32. PubMed ID: 16872548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In situ gel systems as 'smart' carriers for sustained ocular drug delivery.
    Agrawal AK; Das M; Jain S
    Expert Opin Drug Deliv; 2012 Apr; 9(4):383-402. PubMed ID: 22432690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thermoresponsive mucoadhesive hybrid gels in advanced drug delivery systems.
    Mfoafo K; Omidi Y; Omidian H
    Int J Pharm; 2023 Apr; 636():122799. PubMed ID: 36914019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation.
    Rençber S; Karavana SY; Şenyiğit ZA; Eraç B; Limoncu MH; Baloğlu E
    Pharm Dev Technol; 2017 Jun; 22(4):551-561. PubMed ID: 27055376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A review on mucoadhesive polymer used in nasal drug delivery system.
    Chaturvedi M; Kumar M; Pathak K
    J Adv Pharm Technol Res; 2011 Oct; 2(4):215-22. PubMed ID: 22247888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.
    Qi H; Chen W; Huang C; Li L; Chen C; Li W; Wu C
    Int J Pharm; 2007 Jun; 337(1-2):178-87. PubMed ID: 17254725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nasal route and drug delivery systems.
    Türker S; Onur E; Ozer Y
    Pharm World Sci; 2004 Jun; 26(3):137-42. PubMed ID: 15230360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.